Kanika Vanshylla

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial.

Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial.

Journal: EBioMedicine
Published: October 03, 2024

Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates.

Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates.

Journal: NPJ vaccines
Published: April 11, 2024

Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool.

Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool.

Journal: Science immunology
Published: November 17, 2023

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits.

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits.

Journal: Nature communications
Published: September 21, 2023

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection.

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection.

Journal: Science advances
Published: July 05, 2023

Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants.

Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants.

Journal: Immunity
Published: April 21, 2023

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.

Journal: JCI insight
Published: November 04, 2022

Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion.

Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion.

Journal: Nature communications
Published: October 21, 2022

Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review.

Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review.

Journal: The Cochrane database of systematic reviews
Published: August 09, 2022

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage.

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage.

Journal: The Lancet. Infectious diseases
Published: August 03, 2022

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 07, 2022

Antibody-mediated neutralization of SARS-CoV-2.

Antibody-mediated neutralization of SARS-CoV-2.

Journal: Immunity
Published: March 28, 2022
Showing 1-12 of 41

Last Updated: 09/26/2026